Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis is a research paper published in JACC Basic to Translational Science (2020). On theSindex it has a DataRank of 0. It has been cited 90 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Stiftelsen för Strategisk Forskning
Grant: IRC15-0067
Cancer Research UK
Grant: 14136
European Research Council
Grant: ERC-STG-2015-679242
Ministero della Salute
Grant: GR-2018-12366423
Hjärt-Lungfonden
Grant: 2016-0134
Hjärt-Lungfonden
Grant: 2016-0315
Vetenskapsrådet
Grant: 2017-02554
Medical Research Council Canada
Grant: G1000143
Diet, lifestyle and biological determinants of health and disease: the EPIC-Norfolk population study
Medical Research Council Canada
Grant: NCT00338676
Fondazione Gigi e Pupa Ferrari
Grant: FPF-14
National Institute for Health Research (NIHR)
Grant: NF-SI-0617-10149
NHLBI NIH HHS
Grant: R01 HL128550
European Research Council
Grant: 679242
Integrative omics of heart failure to inform discovery of novel drug targets and clinical biomarkers
Medical Research Council
Grant: MC_UU_00006/1
Medical Research Council
Grant: MC_UU_12015/1
Knut and Alice Wallenberg Foundation
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01HL128550-04
Molecular and Genetic Epidemiology of Lp(a)-mediated Calcific Aortic Valve Disease
Crafoordska Stiftelsen
Daimler und Benz Stiftung
Deutsche Forschungsgemeinschaft
Merck
Boehringer Ingelheim
Ionis Pharmaceuticals
National Heart, Lung, and Blood Institute
National Institutes of Health
Novartis
Skånes universitetssjukhus
Assistance Publique - Hôpitaux de Paris
Edwards Lifesciences
Fonds de Recherche du Québec - Santé
Medtronic
Pfizer
Fédération Française de Cardiologie
Akebia Therapeutics
Horizon 2020
Knut och Alice Wallenbergs Stiftelse
Canadian Institutes of Health Research
Conseil Régional des Pays de la Loire
Fritz Thyssen Stiftung
Servier
FWCI
9.20
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 2 of Myeloid CCN3 protects against aortic valve calcification
Additional file 2 of Myeloid CCN3 protects against aortic valve calcification
Additional file 1 of Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells
Additional file 1 of Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells
Additional file 2 of Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells
Additional file 2 of Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells
Additional file 3 of Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells
Additional file 3 of Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells
Dataset related to the article "Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis"
Dataset related to the article "Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis"